Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
CORMORANT ASSET MANAGEMENT LP | 11-14-2023 | 09-30-2023 | 49 | 1,714,347,327 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
GH RESEARCH PLC | ORDINARY SHARES | 101 | $5,960,082 | 593,043 | 0.00 | 0.00 | 0 | 0.00 | 09-30-2023 |
RAPT THERAPEUTICS INC | COM | 102 | $5,401,500 | 325,000 | 0.00 | 0.00 | 0 | 0.00 | 09-30-2023 |
VERVE THERAPEUTICS INC | COM | 103 | $4,641,000 | 350,000 | 0.00 | 0.00 | 0 | 0.00 | 09-30-2023 |
STOKE THERAPEUTICS INC | COM | 104 | $4,285,960 | 1,087,807 | 0.00 | 0.00 | 0 | 0.00 | 09-30-2023 |